Account

Table 4 Therapeutic efficacy data of Caelyx® and ED-lip in mice bearing C26 tumor

From: Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma

Groups	TTE^a (day ± SD)	TGD^b (%)	MST^c (Day)
PBS	26.146 ± 6.2	0	29.6
Caelyx®	41.102 ± 8.6	68.68	44.1
ED-lip	49.749 ± 2.2	90.27	Undefined^d

^a Time to reach end-point
^b Tumor growth delay (in comparison with buffer group)
^c Median survival time
^d Due to complete curing of 3 mice in ED-lip group it is not possible to calculate MST for this group and reported as undefined

Back to article page